Ryan A. Murr
Areas of Practice
Ryan Murr, a partner in the firm’s Business Law Department, specializes in corporate and securities law. His practice focuses on serving clients in the technology, life sciences and clean-tech industries. Mr. Murr joined Goodwin Procter in 2007.
Work for Clients
Mr. Murr represents issuers, investors and underwriters in connection with securities offerings and regularly serves as principal outside counsel to publicly traded and privately held companies. In this role, he advises management teams and boards of directors on corporate law matters, SEC reporting, corporate governance and strategic transactions, including mergers and acquisitions. Mr. Murr’s work in the securities offerings area includes representation of: a Fortune 500 research, engineering and systems integration company in $1.3 billion initial public offering and related corporate restructuring, including payment of $2.45 billion dividend; a French enterprise software company in $260 million multinational exchange offer to redomicile in the United States; a Fortune 1,000 pharmaceutical company in $1.1 billion Rule 144A debt offering; numerous public companies in connection with securities matters for various acquisitions and divestitures, including a $2.2 billion front-end tender offer for a Fortune 500 media company and a $366 million cash-election merger for a financial services company; issuers and underwriters in initial public offerings for technology and biotechnology companies; and various public biotechnology, information-technology and nanotech companies and investors in connection with follow-on stock offerings, including underwritten offerings, PIPEs, registered-direct transactions and at-the-market (ATM) offerings. In the mergers and acquisitions...more » Mr. Murr represents issuers, investors and underwriters in connection with securities offerings and regularly serves as principal outside counsel to publicly traded and privately held companies. In this role, he advises management teams and boards of directors on corporate law matters, SEC reporting, corporate governance and strategic transactions, including mergers and acquisitions. Mr. Murr’s work in the securities offerings area includes representation of: a Fortune 500 research, engineering and systems integration company in $1.3 billion initial public offering and related corporate restructuring, including payment of $2.45 billion dividend; a French enterprise software company in $260 million multinational exchange offer to redomicile in the United States; a Fortune 1,000 pharmaceutical company in $1.1 billion Rule 144A debt offering; numerous public companies in connection with securities matters for various acquisitions and divestitures, including a $2.2 billion front-end tender offer for a Fortune 500 media company and a $366 million cash-election merger for a financial services company; issuers and underwriters in initial public offerings for technology and biotechnology companies; and various public biotechnology, information-technology and nanotech companies and investors in connection with follow-on stock offerings, including underwritten offerings, PIPEs, registered-direct transactions and at-the-market (ATM) offerings. In the mergers and acquisitions arena, Mr. Murr has represented: a Fortune 500 research, engineering and systems integration company in sale of telecom subsidiary to private equity buyers for $1.35 billion; a Fortune 1,000 pharmaceutical company in connection with key aspects of $12.8 billion stock-for-stock merger; an integrated circuit manufacturer in $330 million tender offer sale; an enterprise software company in sale of subsidiary for $355 million in connection with bankruptcy reorganization; a network storage company in $310 million tender offer sale; and various public biotechnology and information-technology companies in connection with significant acquisitions and divestitures, including acquisitions of targets in Australia, Japan, and the United Kingdom. Mr. Murr’s SEC reporting and corporate governance work includes representation of NYSE, Nasdaq and AMEX-listed companies in connection with SEC reporting and corporate governance matters, including Sarbanes-Oxley Act compliance; advising public companies regarding takeover defenses and fiduciary duties in a merger context, including the adoption of stockholder rights plans (“poison pills”); and representation of foreign technology and biotechnology companies in connection with American Depositary Receipt (ADR) facilities and U.S. securities law matters. less »
Professional Activities
Mr. Murr is a member of the American Bar Association, Business Law Section (Committee on Negotiated Acquisitions); San Francisco and San Diego Bar Associations; BIOCOM and the State Bar of California, Business Law Section. He is also a member of the Clean Tech Advisory Board.
Publications/Presentations
Mr. Murr has written on best practices in corporate governance (Inside the Minds: best Practices for Corporate Governance and Compliance, Aspatore Books, a Thomson Business) and has spoken at conferences on corporate governance matters. He has also presented on securities law and effective negotiating strategies and tactics. While attending law school, Mr. Murr served as Lead Articles Editor for the San Diego Law Review.
Professional Experience
Prior to joining Goodwin Procter, Mr. Murr was a partner in the Corporate Practice Group at Heller Ehrman LLP.
Bar and Court Admissions
Mr. Murr is admitted to practice in California.
Education
J.D., University of San Diego School of Law, 1998 (magna cum laude, Order of the Coif)
M.A., University of San Diego College of Arts and Sciences, 1998
B.A., University of Oregon Honors College, 1993
|